ASIA GOUT DISEASE TREATMENT MARKET ANALYSIS

Asia Gout Disease Treatment Market, By Drug Class (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Colchicine, and Urate-lowering Agents), By Route of Administration (Oral and Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Country (China, India, Japan, South Korea, Thailand, Indonesia, Singapore, Vietnam, and Rest of Asian Countries) -

Published In : Jul 2023
Code : CMI4141
Pages :175
Formats :
Excel and PDF
Industry : Pharmaceutical

Asia Gout Disease Treatment MarketSize and Trends

The Asia gout disease treatment market is estimated to be valued at US$ 904.7 Million in 2023 and is expected to exhibit a CAGR of 9.2% during the forecast period (2023-2030).Asia Gout Disease Treatment Market Trends:

The gout therapeutics market is primarily driven by the increasing prevalence of this condition due to changing lifestyle patterns and the growing geriatric population. Globally, the life expectancy of people is increasing, which has led to a rise in the geriatric population. This trend has led to a higher incidence of this condition and per capita demand for its therapeutics, thus positively affecting the market. As a result of the increased incidence of gout and the link between alcohol intake and gout, higher alcohol intake is likely to fuel the expansion of the gout therapeutics market over the projected period.